Clinical Trial Update: Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of Roxadustat (FG-4592) for anemia in end-stage renal disease patients newly initiating dialysis; study status compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in Incident Dialysis Patients
• Chronic Kidney Disease-related Anemia
• End-stage Renal Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Anemia in Incident Dialysis Patients | Phase 3 | Status: COMPLETED | Results posted: 2021-10-01